Short-term maternal outcomes after intraoperative administration of prophylactic oxytocin during cesarean sections: a retrospective cohort study with a comparison of different administration protocols

Read full text Summarise with VIRAT
Authors: Jakob Thomas Buslowicz, Dörthe Brüggmann, Ammar Al Naimi, Samira Catharina Hoock, Eileen Deuster, Wiebke Schaarschmidt, Anne Kristina Kämpf, Vanessa Neef, Kai D. Zacharowski, Frank Louwen, Anna Elisabeth Hentrich
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: The objective of this study was to evaluate the impact of different intraoperative prophylactic oxytocin regimens on maternal blood loss during cesarean section, and to compare effects in procedures performed before versus after onset of labor. METHODS: This retrospective cohort study was conducted at a tertiary care center over 15 years (2006-2021). A total of 1996 cesarean sections were identified, of which 1504 women with complete pre- and postoperative hemoglobin values were included in hemoglobin delta analyses. All 1996 women were considered for descriptive and binary outcome analyses. The study population was stratified into four intraoperative oxytocin exposure groups (0 IU, 3 IU, > 3 up to ≤ 13 IU, and > 13 IU) and further analyzed according to timing before or after onset of labor. The primary outcome was perioperative hemoglobin delta, while secondary outcomes included estimated intraoperative blood loss and binary maternal outcomes such as transfusion, uterine atony, and B-Lynch procedure. RESULTS: In cesarean sections before onset of labor, very high intraoperative oxytocin doses (> 13 IU) were associated with significantly increased adjusted blood loss (+ 315 ml, p = 0.007), while intermediate doses (+ 270 ml, p = 0.009) also showed higher losses compared with no oxytocin. Hemoglobin decline was greater in the 3 IU and > 3 up to ≤ 13 IU groups, but not in the > 13 IU group. In cesarean sections after onset of labor, women receiving very high doses likewise had significantly higher blood loss (+ 170 ml, p = 0.004), whereas a modest reduction was observed with 3 IU (- 116 ml, p = 0.014). Estimated blood loss did not reliably correlate with hemoglobin decline, and no consistent dose-response benefit of higher oxytocin administration was observed. CONCLUSION: Very high intraoperative oxytocin doses were not associated with reduced blood loss and were frequently administered in women at increased bleeding risk, suggesting confounding by indication. These results should therefore be regarded as hypothesis-generating rather than definitive evidence to guide prophylactic dosing.

Fields of Study & Subjects

Maternal and fetal healthcare Maternal and Perinatal Health Interventions Blood transfusion and management

Publication details

Journal / source
Archives of Gynecology and Obstetrics
Volume
313
Issue
1
Publication date
28 March 2026
Language
EN